Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RoosterBio provides standardized adult human mesenchymal stem/stromal cell products and bioprocess media systems that enable rapid development of advanced therapies. Their solutions are widely cited in peer-reviewed literature (>350 articles since 2015) and are used as ancillary/raw materials in multiple ongoing/planned registered clinical trials globally. The company’s cGMP-grade products support translation from concept to first-in-human testing through to commercial manufacturing
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RoosterBio.